Physician profile
Igor Ryndin
NPI 1437172525
$10,157.39
in general payments reported to CMS, 2019-2025
40 companies · $1,174 in 2025
The $1,174 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,475 · 2020: $1,268 · 2021: $1,193 · 2022: $1,961 · 2023: $1,795 · 2024: $1,290 · 2025: $1,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,105 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,104.84 |
| Education | $154.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $2,545.95 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $1,544.21 | 2019-2025 | Myrbetriq, Xtandi, Veozah |
| Boston Scientific Corporation | $1,259.57 | 2019-2024 | Spaceoar Vue System - 10ml, Rezum Generator |
| Urovant Sciences INC | $1,044.13 | 2021-2022 | |
| Pfizer INC. | $754.19 | 2019-2025 | |
| Neotract INC. | $329.69 | 2019-2020 | |
| Allergan, INC. | $266.39 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $247.17 | 2019-2023 | Xiaflex, Aveed |
| Axonics, INC. | $232.49 | 2020 | |
| Abbvie INC. | $229.65 | 2020-2025 | Botox, Lupron Depot |
| Myovant Sciences INC. | $150.84 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $150.13 | 2019-2025 | |
| Tolmar Pharmaceuticals, INC. | $146.87 | 2020-2022 | |
| Medtronic, INC. | $127.23 | 2022 | |
| Myriad Genetic Laboratories, INC. | $120.91 | 2022-2024 | Prolaris |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Igor Ryndin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.